Publisher
Springer Berlin Heidelberg
Reference75 articles.
1. Amodio P, Gatta A (2005) Neurophysiological investigation of hepatic encephalopathy. Metab Brain Dis 20(4):369–379
2. Andermann E, Andermann F, Carpenter S, Wolfe LS, Nelson R, Patry G, Boileau J (1986) Action myoclonus-renal failure syndrome: a previously unrecognized neurological disorder unmasked by advances in nephrology. Adv Neurol 43:87–103
3. Atterbury CE, Maddrey W, Conn HO (1978) Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial. Am J Dig Dis 23:398–406
4. Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, Sigal S et al (2010) Rifaximin treatment in hepatic encephalopathy. N Engl J Med 362(12):1071–1081
5. Ben-Ami H, Nagachandran P, Mendelson A, Edoute Y (1999) Drug-induced hypoglycemic coma in 102 diabetic patients. Arch Intern Med 159(3):281–284